Streetbeat News

Price Targets

CRL

Redburn Atlantic has initiated coverage on Charles River Laboratories (NYSE:CRL) with a Sell rating and set a price target of $151.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:14 pm

AVDX

Goldman Sachs analyst Will Nance has maintained a 'Sell' rating on AvidXchange Holdings and lowered the price target from $9 to $7.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:13 pm

APP

Goldman Sachs analyst Eric Sheridan has downgraded AppLovin (NASDAQ:APP) from Buy to Neutral, while raising the price target from $103 to $150.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:12 pm

AMX

Goldman Sachs analyst Vitor Tomita maintains a Buy rating on America Movil (NYSE:AMX) but lowers the price target from $21 to $20.8.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:10 pm

CLSD

Chardan Capital has reiterated its Buy rating for Clearside Biomedical (NASDAQ:CLSD) and maintained a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:09 pm

MEDP

Redburn Atlantic has initiated coverage on Medpace Holdings with a Buy rating and set a price target of $404.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:08 pm

AFRM

Goldman Sachs analyst Will Nance has maintained a Buy rating on Affirm Holdings and raised the price target from $46 to $54.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:06 pm

FROG

DA Davidson analyst Gil Luria maintains a Buy rating on JFrog (NASDAQ:FROG) with a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:06 pm

GTLB

DA Davidson has maintained a Neutral rating on GitLab with a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:04 pm

APPN

DA Davidson analyst Gil Luria maintains a Neutral rating on Appian (NASDAQ:APPN) with a $33 price target.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 4:02 pm